Inventaire - your friends and communities are your best library

Targeting the renin-angiotensin-aldosterone system in heart failure

author

Allan D. Struthers

1952 -

Chim C. Lang

published in: Nature Reviews Cardiology

date of publication: 2013-01-15

language: English

main subject: heart failure

Cites articles 106

Date

Title

Authors

2013-03

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
2013-01-01

Aortic valvular heart disease: Is there a place for angiotensin-converting-enzyme inhibitors?

Allan D. Struthers, Chim C. Lang
2012-08-01

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Kenneth Dickstein, Christian Funck-Brentano, Olav Wendelboe Nielsen, Volkmar Falk, Claudio Ceconi, Tiny Jaarsma, Aldo P. Maggioni, Paulus Kirchhof, Juhani Knuuti, Frans H Rutten, Piotr Ponikowski, Gregory Lip, Faiez Zannad, Gerasimos Filippatos, Stephan Windecker, Lars Køber, Stefan D. Anker, Per Anton Sirnes, Angelo Auricchio, Michał Tendera, Jeroen Joost Bax, Udo Sechtem, Andreas Zeiher, Stein Ørn, Adam Torbicki, Philippe Kolh, Arno W. Hoes, Janina Stępińska, Adriaan A Voors, John McMurray, Helmut Baumgartner, Christi Deaton, Robert Fagard, Burkert Pieske, Henry J Dargie, Stamatis Adamopoulos, Cândida Fonseca, Per K Rønnevik, Juerg Schwitter, John T. Parissis, David Hasdai, Cyril Moulin, Luis Almenar Bonet, Panayiotis Avraamides, Hisham A. Ben Lamin, Peter James Cowburn, Perry M Elliott, Frank Arnold Flachskampf, Guido Francesco Guida, Suzanna Hardman, Bernard Iung, ESC Committee for Practice Guidelines (CPG)
2012-08-01

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients

Eric Boersma, Jean-Jacques Mourad
2012-05-01

Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study

Faiez Zannad, Bertram Pitt, Karl Swedberg, Henry Krum, Dirk J van Veldhuisen, John McMurray, Harry Shi, EMPHASIS-HF Study Investigators
2012-11-01

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction

Lina Benson
2012-07-23

(Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function

Jaana Rysä, Raisa Serpi, Tuula Salo
2012-03-01

New roles for renin and prorenin in heart failure and cardiorenal crosstalk

Dirk J van Veldhuisen, Hans L Hillege, Nicolas F Schroten, Mariusz Szymanski, Cajm Gaillard
2012-11-03

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

John McMurray, Frederik Persson, ESICM H1N1 Registry Contributors, Steven M. Haffner
2012-04-01

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

Kenneth Dickstein, Lars Køber, Henry Krum, William T Abraham, John McMurray, Barry M. Massie
2012-08-26

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Burkert Pieske, Adriaan A Voors, John McMurray, Victor C Shi, Michael R Zile, Milton Packer, Elisabeth Kraigher-Krainer, Amil M Shah, Toni Bransford
2012-11-01

Heart failure therapy: what should clinicians believe?
2012-09-01

Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study

Luis Miguel Ruilope, Massimo Volpe, Roland E. Schmieder
2011-12-06

Reverse remodeling in heart failure--mechanisms and therapeutic opportunities
2011-08-01

Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis

Allan D. Struthers, Alexander S Doney, Chim C. Lang
2011-11-01

The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study

Allan D. Struthers, Alexander S Doney, Chim C. Lang
2011-07-01

Pacing-induced heart disease: understanding the pathophysiology and improving outcomes

Chim C. Lang
2011-03-01

Renin, (pro)renin and receptor: an update
2011-02-10

Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction

Hicham Skali, Aldo P. Maggioni, John McMurray, Lars Køber, Jean Rouleau, Marc A Pfeffer, Amil M Shah
2011-04-04

Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study.

Aldo P. Maggioni, Bertram Pitt, John McMurray
2011-01

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

John McMurray, Lars Køber, Henry Krum, Kenneth Dickstein, William T Abraham, Claudio R Gimpelewicz, Barry M. Massie, Bernard Reimund
2011-11-15

Renin-angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block

Chim C. Lang, Allan D. Struthers
2010-01-01

Clinical practice. Systolic heart failure

John McMurray
2010-06-01

Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.

Harlan M. Krumholz, Joseph S. Ross, Héctor Bueno, Sharon-Lise Normand, Elizabeth E Drye, Jeptha P Curtis, Mikhail Kosiborod, María T Vidán, Judith H Lichtman
2010-11-01

Effect of eplerenone versus spironolactone on cortisol and hemoglobin A₁(c) levels in patients with chronic heart failure
2010-11-14

Eplerenone in patients with systolic heart failure and mild symptoms

Faiez Zannad, Bertram Pitt, Karl Swedberg, Henry Krum, Dirk J van Veldhuisen, John McMurray, Harry Shi, EMPHASIS-HF Study Group
2010-05-18

Spironolactone use and renal toxicity: population based longitudinal analysis

Allan D. Struthers, Tom Fahey, Thomas Macdonald
2010-10-01

Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial

Gilles Montalescot, Faiez Zannad, Farzin Beygui
2010-03-18

Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction

Bertram Pitt, James E Udelson
2010-12-07

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
2010-10-01

Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats
2010-11-30

Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).

Aldo P. Maggioni, Gregg C. Fonarow, Mihai Gheorghiade, Faiez Zannad, Claudio R Gimpelewicz, Eldrin F Lewis, Jaco Botha

Article - wd:Q38074092

Welcome to Inventaire

the library of your friends and communities

learn more